Answers are grounded in this paper and cite their sources.
Aprotinin showed high efficacy and safety in a prospective study of combination therapy for hospitalized patients with moderate to severe COVID-19 pneumonia.
No takes yet. Share an insight, caveat, or question.
Ivashchenko et al. (2020) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: